Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial
Samir Kapadia(Cleveland Clinic), Martin B. Leon(Columbia University Irving Medical Center), Molly Szerlip(Heart Hospital Baylor Plano), E. Murat Tuzcu(Cleveland Clinic), Michael J. Mack(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Susheel Kodali(Columbia University Irving Medical Center), D. Craig Miller(Harvard University), Lars G. Svensson(Cleveland Clinic), John G. Webb(St. Paul's Hospital), Raj Makkar(Cedars-Sinai Medical Center), Suzanne J. Baron(Harvard University), Jeevanantham Rajeswaran(Cleveland Clinic Lerner College of Medicine), Howard C. Herrmann(University of Pennsylvania), Chetan Huded(Health Innovations (United States)), David J. Cohen(Baim Institute for Clinical Research), Eugene H. Blackstone(Cleveland Clinic), Craig R. Smith(University of Arizona), Vinod H. Thourani(Valve (United States))
Cited by 77
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
|New England Journal of Medicine|2011|6.4k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k